Bio-Optronics Releases New Version of CTMS Technology
Bio-Optronics' Clinical Conductor CTMS team announced new features in the latest release of Clinical Conductor
Bio-Optronics' Clinical Conductor CTMS team announced new features in the latest release of Clinical Conductor, one of which is multiple CTMS configuration flexibility. These configurations are designed for research sites, site networks, CROs, hospitals, health systems and sponsors feature sets and functionalities required by their specific organization.
In addition to the configurations in this release, Clinical Conductor includes more financial functionality to give organizations even greater insight into their study finances.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Pfizer Reports Strong Phase III Results for Hympavzi in Hemophilia Patients with Inhibitors
June 26th 2025The Phase III BASIS trial found that once-weekly subcutaneous Hympavzi reduced treated bleed rates by 93% in patients with hemophilia A or B with inhibitors, offering a promising new prophylactic option for a population with limited therapeutic choices.
